Case Report
Copyright ©The Author(s) 2021.
World J Clin Cases. Dec 26, 2021; 9(36): 11382-11391
Published online Dec 26, 2021. doi: 10.12998/wjcc.v9.i36.11382
Figure 1
Figure 1 The plain phase, the arterial phase, the portal vein phase, and the delayed phase. A: Contrast-enhanced computed tomography shows a 40-mm-diameter, hypovascular mass in the head of the pancreas, the inside is uneven, and the boundaries are relatively clear (white arrows); B-D: The lesion heterogeneously and slightly enhances as the phase progresses. The main pancreatic duct upstream of the mass is severely dilated (yellow arrows).
Figure 2
Figure 2 Abdominal ultrasonography shows a well-defined, circular, hypoechoic mass in the head of the pancreas (arrow).
Figure 3
Figure 3 Magnetic resonance imaging and magnetic resonance cholangiopancreatography. A-C: Magnetic resonance imaging shows low intensity on T1- and T2-weighted images and high intensity on diffusion-weighted images (white arrows); D: Magnetic resonance cholangiopancreatography shows dilatation of the main pancreatic duct upstream of the mass (yellow arrow).
Figure 4
Figure 4 18F-fluorodexyglucose positron emission tomography also shows a strong increase in 18F-fluorodexyglucose with a maximum standardized uptake value of 5. 56 (arrow).
Figure 5
Figure 5 Endoscopic ultrasound-guided fine needle aspiration is performed with a 19-gauge needle.
Figure 6
Figure 6 Hematoxylin and eosin staining and immunostaining. A: Hematoxylin and eosin staining (H&E) of a biopsy sample obtained by endoscopic ultrasound-guided fine needle shows a pseudopapillary structure and a pseudorosette structure in some parts on H&E staining (× 20); B and C: Immunostaining shows that the tumor is β-catenin-positive (B, × 20) and CD10-positive (C, × 20).
Figure 7
Figure 7 Hematoxylin and eosin staining and pathological findings. A: Cut surface of the resected specimen is a white solid mass separate from the pancreas; B: Histologically, hematoxylin and eosin staining (× 200) shows a pseudopapillary structure and a pseudorosette structure like the biopsy sample obtained by endoscopic ultrasound-guided fine needle; C and D: Immunostaining also shows that the tumor is β-catenin-positive (C, × 20) and CD10-positive (D, × 20). The pathological findings result in the final diagnosis of SPN. The main pancreatic duct is very narrow; E: Histologically, there is no malignant infiltration, and the tumor surrounds the main pancreatic duct, compressing it from all directions (× 40).